Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Auum Inc. is a Canadian life sciences company specializing in the research, development, and distribution of high-performance mammalian-sourced Omega-3 supplements. The company's flagship product line, Auum Mammalian Oil, is derived from seal oil and is uniquely formulated to provide a balanced ratio of EPA, DHA, and docosapentaenoic acid (DPA), a fatty acid often missing in traditional fish-based supplements. Auum emphasizes a sublingual delivery method designed to ensure rapid absorption and maximum bioavailability by bypassing the digestive system. Their research-backed formulations are primarily marketed for supporting neurological health, cardiovascular function, and the management of inflammatory conditions in both human and veterinary applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Auum.